TELIX Pharmaceuticals Ltd (tlx) Logo

TELIX Pharmaceuticals Ltd (TLX)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News
Announcements

TLX ASX Chart

Snapshot

Telix Pharmaceuticals Limited (TLX) is a global biopharmaceutical company engaged in the development and commercialization of targeted therapeutic and diagnostic radiopharmaceuticals, along with supporting medical technologies. Headquartered in Melbourne, Australia, Telix maintains strategic international operations across the United States, Brazil, Canada, Europe (Belgium and Switzerland), and Japan.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) -3.69%
vs ASX 200 (1yr) -49.84%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 127 of 2,340
Sector Rank 9 of 241

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies MSB / PYC / PYCDA
EPS -$0.03
DPS $0.00
Book Value Per Share $1.712

Broker Consensus

TLX is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office North Melbourne VIC 3051
Website www.telixpharma.com
Registry MUFG Corporate Markets (AU) Limited
Auditor PricewaterhouseCoopers
Date Listed 15 Nov 2017

Upcoming Calendar (Forecasted)

Date Event
20/08/2026 Report (Interim)
19/02/2027 Report (Prelim)
19/02/2027 Report (Annual)

Former Company Names

  • TELIX Pharmaceuticals Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

TLX directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
26/05/26 Christian Behrenbruch Issued 366,966 $13.23 $4,854,960 Issue of securities
26/05/26 Marie McDonald Issued 23,139 $13.23 $306,128 Issue of securities
26/05/26 William (Bill) Jellison Issued 21,597 $13.23 $285,728 Issue of securities
26/05/26 Maria Rivas Issued 21,597 $13.23 $285,728 Issue of securities
26/05/26 David Gill Issued 30,048 $13.23 $397,535 Issue of securities
29/04/26 Christian Behrenbruch Buy +67,935 $14.67 $996,699 On-market trade
16/03/26 Christian Behrenbruch Expiry 20,045 $10.98 $220,094 As advised by the company
05/11/25 Christian Behrenbruch Issued 100,708 $4.38 $441,101 Exercise of options
05/11/25 Christian Behrenbruch Exercise 100,708 $4.38 $441,101 Exercise of options
13/06/25 Christian Behrenbruch Issued 169,078 $11.10 $1,876,796 Director remuneration
06/03/25 Christian Behrenbruch Expiry 46,558 $28.06 $1,306,417 As advised by the company
05/03/25 Marie McDonald Buy +3,719 $26.91 $100,078 On-market trade
05/03/25 Tiffany Olson Buy +11,315 $28.23 $319,422 On-market trade
27/02/25 Harry McCann Sell +30,000 $30.43 ($912,900) On-market trade
27/02/25 Christian Behrenbruch Sell +2,000,000 $29.50 ($59,000,000) Off-market trade
26/06/24 Christian Behrenbruch Issued 144,037 $5.94 $856,158 As advised by the company
18/01/24 Christian Behrenbruch Buy +153,298 $11.00 $1,686,278 Exercise of options
18/01/24 Christian Behrenbruch Exercise 153,298 $11.00 $1,686,278 Exercise of options
18/01/24 Christian Behrenbruch Cancelled 46,702 $11.00 $513,722 Cancellation of securities
30/05/23 Christian Behrenbruch Issued 120,268 $2.97 $356,738 Director remuneration
16/03/23 Tiffany Olson Buy +51,305 $6.69 $343,385 On-market trade
12/12/22 Tiffany Olson Buy +10,930 $6.70 $73,255 On-market trade
09/11/22 Jann Skinner Issued 495,000 $1.09 $539,550 Exercise of options
09/11/22 Jann Skinner Exercise 495,000 $1.09 $539,550 Exercise of options
03/06/22 Tiffany Olson Buy +33,000 $4.11 $135,665 On-market trade
18/05/22 Christian Behrenbruch Issued 139,672 $2.43 $339,752 Issue of securities
18/05/22 Tiffany Olson Issued 52,070 $2.19 $113,850 Issue of securities
27/04/22 Oliver Buck Buy +250,000 $4.37 $1,092,500 On-market trade
03/02/22 Christian Behrenbruch Buy +400,000 $1.09 $436,000 Exercise of options
03/02/22 Christian Behrenbruch Exercise 400,000 $1.09 $436,000 Exercise of options
27/01/22 Christian Behrenbruch Sell +2,000,000 $7.70 ($15,400,000) As advised by the company
27/01/22 Andreas Kluge Sell +2,000,000 $7.70 ($15,400,000) As advised by the company
29/09/21 Mark Nelson Buy +990,000 $0.85 $841,500 Exercise of options
29/09/21 Mark Nelson Exercise 990,000 $0.85 $841,500 Exercise of options
29/09/21 Harry McCann Buy +990,000 $0.85 $841,500 Exercise of options
29/09/21 Harry McCann Exercise 990,000 $0.85 $841,500 Exercise of options
12/05/21 Christian Behrenbruch Issued 100,708 $3.71 $373,626 Issue of options
02/11/20 Oliver Buck Buy +165,330 $0.85 $140,530 Exercise of options
02/11/20 Oliver Buck Exercise 165,330 $0.85 $140,530 Exercise of options
12/05/20 Christian Behrenbruch Issued 200,000 $1.47 $294,000 Issue of options
27/02/20 Mark Nelson Buy +400,000 $1.45 $580,000 On-market trade
13/02/20 Oliver Buck Exercise 164,835 $0.85 $140,110 Exercise of options
13/02/20 Oliver Buck Buy +164,835 $0.85 $140,110 Exercise of options
13/02/20 Oliver Buck Buy +164,835 $0.85 $140,110 Exercise of options
13/02/20 Oliver Buck Exercise 164,835 $0.85 $140,110 Exercise of options
17/09/19 Oliver Buck Buy +164,835 $0.85 $140,110 Exercise of options
17/09/19 Oliver Buck Exercise 164,835 $0.85 $140,110 Exercise of options
13/09/18 Jann Skinner Buy +100,000 $0.85 $85,000 On-market trade
Show All

Director Interests

The current holdings of TLX directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
William (Bill) Jellison 11/05/2026 0 N/A N/A N/A
Maria Rivas 11/05/2026 0 N/A N/A N/A
David Gill 11/05/2026 0 N/A N/A N/A
Christian Behrenbruch 29/04/2026 654,006 20,742,935 N/A N/A
Mark Nelson 30/12/2025 N/A 3,628,750 N/A N/A
Marie McDonald 30/12/2025 N/A 3,719 N/A N/A
Jann Skinner 30/12/2025 N/A 595,000 N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Feb 6, 2026.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
HSBC Custody Nominees (Australia) Limited 53,462,930 15.80%
Citicorp Nominees Pty Limited 31,693,330 9.40%
J P Morgan Nominees Australia Pty Limited 24,921,869 7.40%
ELK River Holdings Pty Ltd 20,675,000 6.10%
Gnosis Verwaltungsgesellschaft Mbh 20,675,000 6.10%
BNP Paribas Nominees Pty Ltd 15,376,442 4.50%
BNP Paribas Noms Pty Ltd 10,433,812 3.10%
Grand Decade Developments Limited 6,000,000 1.80%
BNP Paribas Nominees Pty Ltd i 5,643,043 1.70%
UV Cap Gmbh and Co Kg 4,878,261 1.40%
Merrill Lynch (Australia) Nominees Pty Limited 3,294,701 1.00%
Man Holdings Pty Ltd 3,228,750 1.00%
BNP Paribas Nominees Pty Ltd ii 2,923,857 0.90%
BNP Paribas Noms (Nz) Ltd 2,714,023 0.80%
Netwealth Investments Limited 2,406,576 0.70%
Lightpoint Medical Ltd 1,918,112 0.60%
The Oncidium Foundation 1,846,582 0.60%
Pacific Custodians Pty Limited 1,618,200 0.50%
Ubs Nominees Pty Ltd 1,191,214 0.40%
WHSP Holdings Pty Limited 1,136,783 0.30%
BNP Paribas Nominees Pty Ltd iii 1,120,510 0.30%
Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 22,560 9,981 1,757 1,465 156 35,919

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Elk River Holdings Pty Ltd 06/02/2026 20,675,000 6.10
Gnosis Verwaltungsgesellschaft 06/02/2026 20,675,000 6.10
Citigroup Global Markets Australia Pty Limited 22/05/2026 20,075,111 5.92
State Street Corporation and subsidiaries 07/05/2026 29,545,769 8.71
JPmorgan Chase & Co. and its affiliates 24/04/2026 34,596,714 10.20

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
22-05-26 Citigroup Global Markets Australia Pty Limited 20,075,111 -- 5.92
15-04-26 Challenger Limited and entities 17,763,538 -- 5.24
14-04-26 JPmorgan Chase & Co. and its affiliates 12,917,104 7.70 11.50
07-04-26 Citigroup Global Markets Australia Pty Limited 17,989,697 -- 5.31
18-03-26 Citigroup Global Markets Australia Pty Limited 3,398,897 5.06 6.07
13-03-26 Citigroup Global Markets Australia Pty Limited 17,160,938 -- 5.06
10-03-26 Challenger Limited and entities 17,102,529 -- 5.05
04-03-26 State Street Corporation and subsidiaries 5,160,606 8.32 9.84
17-02-26 JPmorgan Chase & Co. and its affiliates 3,670,395 6.62 7.70
04-02-26 JPmorgan Chase & Co. and its affiliates 3,666,422 5.54 6.62
29-01-26 State Street Corporation and subsidiaries 3,453,550 7.31 8.32
21-01-26 JPmorgan Chase & Co. and its affiliates 18,752,593 -- 5.54
12-11-25 JPmorgan Chase & Co. and its affiliates 17,663,335 -- 5.21
06-10-25 State Street Corporation and subsidiaries 3,504,665 6.29 7.31
23-09-25 Challenger Limited and entities 18,096,417 -- 5.35
03-09-25 Challenger Limited and entities 16,927,111 -- 5.00
21-08-25 Challenger Limited and entities 17,311,650 -- 5.12

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
07-05-26 State Street Corporation and subsidiaries 3,802,612 9.84 8.71
04-05-26 Challenger Limited and entities 17,763,538 5.24 --
24-04-26 JPmorgan Chase & Co. and its affiliates 4,409,800 11.50 10.20
08-04-26 Citigroup Global Markets Australia Pty Limited 17,989,697 5.31 --
01-04-26 Challenger Limited and entities 17,102,529 5.05 --
31-03-26 Citigroup Global Markets Australia Pty Limited 20,559,835 6.07 --
21-01-26 Challenger Limited and entities 18,096,417 5.35 --
20-01-26 JPmorgan Chase & Co. and its affiliates 17,663,335 5.21 --
10-09-25 Challenger Limited and entities 16,927,111 5.00 --
28-08-25 Challenger Limited and entities 17,311,650 5.12 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2025 $24.42 30 June
2024 $18.65 28 June
2023 $11.22 30 June
2022 $4.53 30 June
2021 $6.09 30 June
2020 $1.28 30 June
2019 $1.24 28 June
2018 $0.67 29 June
TLX Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.